Task: Answer the multiple-choice question.
Query: Which drug exhibits a 3.871% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a COc1ccc(CN2CCNCC2)c(OC)c1OC.Cl
b CCOP(=O)(OCC)C1(C(=O)[O-])CCCC1.[NH4+]
c Cn1nc(C(F)(F)F)c(CN2CC(C)(C)C2=O)c1N1CCOCC1
d CC1(C)Oc2ccc(NC(=O)c3ccco3)cc2O1
Answer: b. CCOP(=O)(OCC)C1(C(=O)[O-])CCCC1.[NH4+]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOP(=O)(OCC)C1(C(=O)[O-])CCCC1.[NH4+]
CCOP(=O)(OCC)C1(C(=O)[O-])CCCC1.[NH4+]
azanium;1-diethoxyphosphorylcyclopentane-1-carboxylate